Pharmabiz4d
EMA validates X4 Pharma’s marketing authorization application for mavorixafor to treat WHIM syndrome
EMA validates X4 Pharma’s marketing authorization application for mavorixafor to treat WHIM syndrome: Boston Monday, January 27, 2025, 11:00 Hrs [IST] X4 Pharmaceuticals, a comp ...
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome ...
Elvis Presley's secret autopsy revealed gruesome details of how King really died
The rumours surrounding Elvis Presley's sudden death have plagued his name for decades, but the sealed autopsy report - which ...
verywellhealth24d
What Does It Mean to Be Immunocompromised?
If you are immunocompromised, your immune system is weakened, making you more susceptible to severe illness and infection. Some people are born with a weakened immune system, while others can become ...
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response Across clinical trials, Breyanzi has deliver ...